{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:51:50Z","timestamp":1777477910050,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jtbi.2009.08.029","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T08:53:10Z","timestamp":1252140790000},"page":"548-560","source":"Crossref","is-referenced-by-count":12,"title":["Trade-off between BCG vaccination and the ability to detect and treat latent tuberculosis"],"prefix":"10.1016","volume":"261","author":[{"given":"David J.","family":"Gerberry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2009.08.029_bib1","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/j.vaccine.2008.08.006","article-title":"The effect of Bacille Calmette-Gu\u00e9rin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis","volume":"26","author":"Araujo","year":"2008","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.jtbi.2009.08.029_bib2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jtbi.2009.08.029_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jtbi.2008.06.023","article-title":"Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control","volume":"254","author":"Bhunu","year":"2008","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.jtbi.2009.08.029_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11538-008-9295-4","article-title":"Tuberculosis transmission model with chemoprophylaxis","volume":"70","author":"Bhunu","year":"2008","journal-title":"Bulletin of Mathematical Biology"},{"issue":"8","key":"10.1016\/j.jtbi.2009.08.029_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm0895-815","article-title":"The intrinsic transmission dynamics of tuberculosis epidemics","volume":"1","author":"Blower","year":"1995","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jtbi.2009.08.029_bib6","unstructured":"Centers for Disease Control and Prevention, 1996. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. Morbidity and Mortality Weekly Report: Recommendations and Reports, 45(RR-4)."},{"key":"10.1016\/j.jtbi.2009.08.029_bib7","unstructured":"Centers for Disease Control and Prevention, 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbidity and Mortality Weekly Report: Recommendations and Reports, 49(RR-6), pp. 1\u201354."},{"key":"10.1016\/j.jtbi.2009.08.029_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1098\/rsif.2006.0193","article-title":"Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model for transmission","volume":"4","author":"Cohen","year":"2007","journal-title":"Journal of the Royal Society Interface"},{"key":"10.1016\/j.jtbi.2009.08.029_bib9","series-title":"Mathematical Epidemiology of Infectious Disease","author":"Diekmann","year":"2000"},{"key":"10.1016\/j.jtbi.2009.08.029_bib10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy","volume":"352","author":"Dye","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jtbi.2009.08.029_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","article-title":"Tuberculosis","volume":"362","author":"Frieden","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtbi.2009.08.029_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ije\/dyl213","article-title":"Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG-vaccinated children?","volume":"35","author":"Garc\u00eda-Sancho","year":"2006","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.jtbi.2009.08.029_bib13","unstructured":"Gerberry, D.J., Milner, F.A., 2010. A data-based model for tuberculosis: Who should be vaccinating? Preprint."},{"key":"10.1016\/j.jtbi.2009.08.029_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1098\/rspb.2003.2606","article-title":"The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficay","volume":"271","author":"Gomes","year":"2004","journal-title":"Proceedings of the Royal Society of London B"},{"key":"10.1016\/j.jtbi.2009.08.029_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final Report of the Medical Research Council","volume":"2","author":"Hart","year":"1977","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jtbi.2009.08.029_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2807\/esm.11.03.00604-en","article-title":"European survey of BCG vaccination policies and surveillance in children, 2005","volume":"11","author":"Infuso","year":"2006","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jtbi.2009.08.029_bib17","series-title":"Robbins Basic Pathology","author":"Kumar","year":"2007"},{"key":"10.1016\/j.jtbi.2009.08.029_bib18","unstructured":"Mayo Foundation for Medical Education and Research. Tuberculosis January. Accessed May 21, 2009 from \u3008http:\/\/www.mayoclinic.com\/health\/tuberculosis\/DS00372\/\u3009."},{"issue":"Suppl. 3","key":"10.1016\/j.jtbi.2009.08.029_bib19","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/314075","article-title":"What does tuberculin reactivity after Bacille Calmette-Gu\u00e8rin vaccination tell us?","volume":"31","author":"Menzies","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jtbi.2009.08.029_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/ajrccm\/145.3.621","article-title":"Effect of Bacille Calmette-Gu\u00e9rin vaccination on tuberculin reactivity","volume":"145","author":"Menzies","year":"1992","journal-title":"American Review of Respiratory Disease"},{"issue":"10","key":"10.1016\/j.jtbi.2009.08.029_bib21","first-page":"891","article-title":"The effect of bacille Calmette-Gu\u00e9rin vaccination at birth of tuberculin skin test reactivity in Ugandan children","volume":"3","author":"Musoke Mudido","year":"1999","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jtbi.2009.08.029_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/tpbi.1998.1366","article-title":"Quantifying the intrinsic transmission dynamics of tuberculosis epidemics","volume":"54","author":"Porco","year":"1998","journal-title":"Theoretical Population Biology"},{"issue":"Suppl. 3","key":"10.1016\/j.jtbi.2009.08.029_bib23","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1086\/314073","article-title":"An analysis of some hypothesis related to the Chingelput Bacille Calmette-Gu\u00e9rin trial","volume":"31","author":"Smith","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jtbi.2009.08.029_bib24","unstructured":"Smith, P.G., Moss, A.R., 1994. Epidemiology of tuberculosis. In: Tuberculosis: Pathogenesis, Protection, and Control. ASM Press."},{"issue":"3","key":"10.1016\/j.jtbi.2009.08.029_bib25","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jtbi.2009.08.029_bib26","unstructured":"United States Census Bureau, 2008. Population division. International Data Base, Decemeber 15. Accessed January 9, 2009 from \u3008http:\/\/www.census.gov\/ipc\/www\/idb\/index.html\u3009."},{"issue":"12","key":"10.1016\/j.jtbi.2009.08.029_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.jtbi.2009.08.029_bib28","unstructured":"World Health Organization, 2004. WHO position paper on BCG vaccination. Weekly Epidemiological Record 79 (4), 27\u201338. Accessed on May 5, 2008 from \u3008http:\/\/www.who.int\/wer\u3009."},{"key":"10.1016\/j.jtbi.2009.08.029_bib29","unstructured":"World Health Organization, 2008. Global Tuberculosis Database. Accessed March 12, 2009 from \u3008http:\/\/www.who.int\/tb\/country\/global_tb_database\/en\/\u3009."},{"key":"10.1016\/j.jtbi.2009.08.029_bib30","unstructured":"World Health Organization, 2007. Department of Immunization, Vaccines and Biologicals. WHO vaccine-preventable diseases: monitoring system. 2007 Global Summary. Accessed on March 12, 2009 from \u3008http:\/\/whqlibdoc.who.int\/hq\/2007\/who_ivb_2007_eng.pdf\u3009."},{"issue":"4","key":"10.1016\/j.jtbi.2009.08.029_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2006.02.013","article-title":"The development and impact of tuberculosis vaccines","volume":"124","author":"Young","year":"2006","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jtbi.2009.08.029_bib32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerging Infectious Diseases"}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519309004093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519309004093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T11:45:34Z","timestamp":1558525534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519309004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022519309004093"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2009.08.029","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}